Internal Medicine, Hematology & Oncology · Louisville, KY
NPI
1790710481
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1460 Bluegrass Ave
Louisville, KY, 40215
Phone (502) 361-8496
Groups this clinician bills Medicare through
Medicare paid, 2024
$86K
1,164 services
Medicare patients, 2024
316
Average age 73
Drug cost, 2024
$4.3M
1,845 prescriptions
Company payments, 2025
$1,929
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mohammad I Khan was code 99214 (office e&m - established), 766 times for 249 patients. In total Mohammad I Khan billed 1,164 services in 8 codes, and Medicare paid $86K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-10-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 766 | 249 | $64.01 | $49K |
| 99233 Hospital E&M - Subsequent | Facility | 200 | 53 | $87.85 | $18K |
| 99223 Hospital E&M - Initial | Facility | 78 | 61 | $125.05 | $9,754 |
| 99204 Office E&M - New | Facility | 59 | 59 | $84.61 | $4,992 |
| 99215 Office E&M - Established | Facility | 38 | 27 | $93.84 | $3,566 |
By year: 2022 $102K for 1,327 services; 2023 $92K for 1,214 services; 2024 $86K for 1,164 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mohammad I Khan prescribed most often to Medicare patients was Eliquis (Apixaban), with 176 prescriptions and refills. In total Mohammad I Khan wrote 1,845 Medicare prescriptions that cost $4.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 176 | 271 | 38 | $158K |
| Imbruvica Ibrutinib | 127 | 127 | 11 | $2.0M |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 121 | 121 | 29 | $4,663 |
| Anastrozole Generic | 113 | 317 | 36 | $1,957 |
| Alprazolam Generic | 73 | 73 | 16 | $474 |
| Ondansetron Odt Ondansetron | 52 | 62 | 23 | $2,002 |
| Folic Acid Generic | 48 | 117 | 19 | $337 |
| Warfarin Sodium Generic | 47 | 111 | 11 | $265 |
| Prochlorperazine Maleate Generic | 46 | 46 | 25 | $1,001 |
| Enoxaparin Sodium Generic | 44 | 44 | 14 | $19K |
| Hydroxyurea Generic | 42 | 75 | Under 11 | $639 |
| Oxycodone Hcl Generic | 40 | 40 | Under 11 | $1,236 |
| Dexamethasone Generic | 38 | 51 | 14 | $762 |
| Potassium Chloride Generic | 36 | 54 | 15 | $350 |
| Olanzapine Generic | 35 | 58 | 14 | $900 |
Brand drugs: 485 claims; generic drugs: 1,360 claims; opioid claims: 196.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mohammad I Khan $1,929 ($1,929 in general payments such as food, travel and fees) from 29 companies. The largest payer was Novartis Pharmaceuticals Corporation with $235.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 10 | $235 |
| Daiichi Sankyo Inc. 4568.T | 10 | $235 |
| E.R. Squibb & Sons, L.L.C. BMY | 10 | $186 |
| Pfizer Inc. PFE | 10 | $164 |
| GlaxoSmithKline, LLC. GSK | 6 | $128 |
| Merck Sharp & Dohme LLC MRK | 5 | $114 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $110 |
| Celgene Corporation BMY | 4 | $87.99 |
| Eisai Inc. 4523.T | 5 | $83.92 |
| Astellas Pharma US Inc 4503.T | 3 | $53.52 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.